Hmdb loader
Survey
You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:51 UTC
Update Date2022-03-07 02:51:52 UTC
HMDB IDHMDB0015098
Secondary Accession Numbers
  • HMDB15098
Metabolite Identification
Common NameBromfenac
DescriptionBromfenac, also known as bromfenac sodium or xibrom, belongs to the class of organic compounds known as benzophenones. These are organic compounds containing a ketone attached to two phenyl groups. Bromfenac is a drug which is used for the treatment of postoperative inflammation in patients who have undergone cataract extraction. Amfenac in which the the hydrogen at the 4 position of the benzoyl group is substituted by bromine. Bromfenac is a moderately basic compound (based on its pKa). In humans, bromfenac is involved in bromfenac action pathway. Bromfenac is a potentially toxic compound. It is used for the management of ocular pain and treatment of postoperative inflammation in patients who have undergone cataract extraction. It was withdrawn from the US market in 1998, following concerns over off-label abuse and hepatic failure.
Structure
Data?1582753258
Synonyms
ValueSource
2-Amino-3-(4-bromobenzoyl)benzeneacetic acidChEBI
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acidChEBI
BromfenacoChEBI
BromfenacumChEBI
2-Amino-3-(4-bromobenzoyl)benzeneacetateGenerator
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetateGenerator
Bromfenac sodiumHMDB
XibromHMDB
Sodium bromfenacHMDB
Wyeth brand OF sodium bromfenacHMDB
DuractHMDB
ISV-303HMDB
Chemical FormulaC15H12BrNO3
Average Molecular Weight334.165
Monoisotopic Molecular Weight333.000055902
IUPAC Name2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid
Traditional Namebromfenac
CAS Registry Number91714-94-2
SMILES
NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1
InChI Identifier
InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19)
InChI KeyZBPLOVFIXSTCRZ-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzophenones. These are organic compounds containing a ketone attached to two phenyl groups.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBenzophenones
Direct ParentBenzophenones
Alternative Parents
Substituents
  • Benzophenone
  • Diphenylmethane
  • Aryl-phenylketone
  • Benzoyl
  • Aryl ketone
  • Aniline or substituted anilines
  • Bromobenzene
  • Halobenzene
  • Aryl bromide
  • Aryl halide
  • Vinylogous amide
  • Amino acid
  • Amino acid or derivatives
  • Ketone
  • Carboxylic acid derivative
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Hydrocarbon derivative
  • Organohalogen compound
  • Organopnictogen compound
  • Organobromide
  • Organonitrogen compound
  • Carbonyl group
  • Amine
  • Organic oxygen compound
  • Organic nitrogen compound
  • Organooxygen compound
  • Primary amine
  • Organic oxide
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
Process
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility0.013 g/LNot Available
LogP3.4Not Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.013 g/LALOGPS
logP3ALOGPS
logP3.66ChemAxon
logS-4.4ALOGPS
pKa (Strongest Acidic)3.81ChemAxon
pKa (Strongest Basic)1.59ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area80.39 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity80.26 m³·mol⁻¹ChemAxon
Polarizability29.93 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+167.00630932474
DeepCCS[M-H]-164.64830932474
DeepCCS[M-2H]-197.53430932474
DeepCCS[M+Na]+173.09930932474
AllCCS[M+H]+171.632859911
AllCCS[M+H-H2O]+168.232859911
AllCCS[M+NH4]+174.732859911
AllCCS[M+Na]+175.632859911
AllCCS[M-H]-166.132859911
AllCCS[M+Na-2H]-166.132859911
AllCCS[M+HCOO]-166.232859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
BromfenacNC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C14468.6Standard polar33892256
BromfenacNC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C12653.6Standard non polar33892256
BromfenacNC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C12737.5Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Bromfenac,1TMS,isomer #1C[Si](C)(C)OC(=O)CC1=CC=CC(C(=O)C2=CC=C(Br)C=C2)=C1N2657.2Semi standard non polar33892256
Bromfenac,1TMS,isomer #2C[Si](C)(C)NC1=C(CC(=O)O)C=CC=C1C(=O)C1=CC=C(Br)C=C12769.8Semi standard non polar33892256
Bromfenac,2TMS,isomer #1C[Si](C)(C)NC1=C(CC(=O)O[Si](C)(C)C)C=CC=C1C(=O)C1=CC=C(Br)C=C12709.0Semi standard non polar33892256
Bromfenac,2TMS,isomer #1C[Si](C)(C)NC1=C(CC(=O)O[Si](C)(C)C)C=CC=C1C(=O)C1=CC=C(Br)C=C12616.5Standard non polar33892256
Bromfenac,2TMS,isomer #1C[Si](C)(C)NC1=C(CC(=O)O[Si](C)(C)C)C=CC=C1C(=O)C1=CC=C(Br)C=C13192.8Standard polar33892256
Bromfenac,2TMS,isomer #2C[Si](C)(C)N(C1=C(CC(=O)O)C=CC=C1C(=O)C1=CC=C(Br)C=C1)[Si](C)(C)C2698.8Semi standard non polar33892256
Bromfenac,2TMS,isomer #2C[Si](C)(C)N(C1=C(CC(=O)O)C=CC=C1C(=O)C1=CC=C(Br)C=C1)[Si](C)(C)C2620.6Standard non polar33892256
Bromfenac,2TMS,isomer #2C[Si](C)(C)N(C1=C(CC(=O)O)C=CC=C1C(=O)C1=CC=C(Br)C=C1)[Si](C)(C)C3220.0Standard polar33892256
Bromfenac,3TMS,isomer #1C[Si](C)(C)OC(=O)CC1=CC=CC(C(=O)C2=CC=C(Br)C=C2)=C1N([Si](C)(C)C)[Si](C)(C)C2683.5Semi standard non polar33892256
Bromfenac,3TMS,isomer #1C[Si](C)(C)OC(=O)CC1=CC=CC(C(=O)C2=CC=C(Br)C=C2)=C1N([Si](C)(C)C)[Si](C)(C)C2633.3Standard non polar33892256
Bromfenac,3TMS,isomer #1C[Si](C)(C)OC(=O)CC1=CC=CC(C(=O)C2=CC=C(Br)C=C2)=C1N([Si](C)(C)C)[Si](C)(C)C2948.1Standard polar33892256
Bromfenac,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)CC1=CC=CC(C(=O)C2=CC=C(Br)C=C2)=C1N2915.7Semi standard non polar33892256
Bromfenac,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC1=C(CC(=O)O)C=CC=C1C(=O)C1=CC=C(Br)C=C13000.8Semi standard non polar33892256
Bromfenac,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=C(CC(=O)O[Si](C)(C)C(C)(C)C)C=CC=C1C(=O)C1=CC=C(Br)C=C13145.4Semi standard non polar33892256
Bromfenac,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=C(CC(=O)O[Si](C)(C)C(C)(C)C)C=CC=C1C(=O)C1=CC=C(Br)C=C13055.7Standard non polar33892256
Bromfenac,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC1=C(CC(=O)O[Si](C)(C)C(C)(C)C)C=CC=C1C(=O)C1=CC=C(Br)C=C13359.3Standard polar33892256
Bromfenac,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(C1=C(CC(=O)O)C=CC=C1C(=O)C1=CC=C(Br)C=C1)[Si](C)(C)C(C)(C)C3157.4Semi standard non polar33892256
Bromfenac,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(C1=C(CC(=O)O)C=CC=C1C(=O)C1=CC=C(Br)C=C1)[Si](C)(C)C(C)(C)C3002.3Standard non polar33892256
Bromfenac,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)N(C1=C(CC(=O)O)C=CC=C1C(=O)C1=CC=C(Br)C=C1)[Si](C)(C)C(C)(C)C3334.2Standard polar33892256
Bromfenac,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)CC1=CC=CC(C(=O)C2=CC=C(Br)C=C2)=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3325.5Semi standard non polar33892256
Bromfenac,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)CC1=CC=CC(C(=O)C2=CC=C(Br)C=C2)=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3201.7Standard non polar33892256
Bromfenac,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)CC1=CC=CC(C(=O)C2=CC=C(Br)C=C2)=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3215.2Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Bromfenac GC-MS (Non-derivatized) - 70eV, Positivesplash10-001i-2942000000-55d5af00fe6fa398bead2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Bromfenac GC-MS (1 TMS) - 70eV, Positivesplash10-000i-5391000000-a985cfcf083f34c1b1552017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Bromfenac GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bromfenac 10V, Positive-QTOFsplash10-00lr-0039000000-8bc362a4cdf601ba45d12016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bromfenac 20V, Positive-QTOFsplash10-000i-0292000000-5eada8c7771779cb03532016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bromfenac 40V, Positive-QTOFsplash10-0540-2950000000-5f5aed8a6d28056c567a2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bromfenac 10V, Negative-QTOFsplash10-001r-0059000000-17d7c340ec08a0adaba22016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bromfenac 20V, Negative-QTOFsplash10-001r-1298000000-1d237d5738d709e7bf6d2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bromfenac 40V, Negative-QTOFsplash10-0zgi-3892000000-27126ed6eaa7f4fe957e2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bromfenac 10V, Positive-QTOFsplash10-00lr-0029000000-f6ac38419ec90ea82b482021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bromfenac 20V, Positive-QTOFsplash10-001i-0922000000-65ab9952df50df9d5a8a2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bromfenac 40V, Positive-QTOFsplash10-001i-0920000000-17efdd1a42d366c249412021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bromfenac 10V, Negative-QTOFsplash10-000i-0090000000-44cbc50fb0fa3719a78c2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bromfenac 20V, Negative-QTOFsplash10-000i-1190000000-61dfc1dbf6f576473d582021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bromfenac 40V, Negative-QTOFsplash10-003i-4091000000-4388b82a5f2e1d637fdd2021-10-11Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Cytoplasm
  • Membrane
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00963 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00963 details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB00963
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID54730
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkBromfenac
METLIN IDNot Available
PubChem Compound60726
PDB IDNot Available
ChEBI ID240107
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available

Enzymes

General function:
Involved in peroxidase activity
Specific function:
Mediates the formation of prostaglandins from arachidonate. May have a role as a major mediator of inflammation and/or a role for prostanoid signaling in activity-dependent plasticity.
Gene Name:
PTGS2
Uniprot ID:
P35354
Molecular weight:
68995.625
References
  1. Waterbury LD, Silliman D, Jolas T: Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Curr Med Res Opin. 2006 Jun;22(6):1133-40. [PubMed:16846546 ]
  2. Sanchez-Matienzo D, Arana A, Castellsague J, Perez-Gutthann S: Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports. Clin Ther. 2006 Aug;28(8):1123-32. [PubMed:16982289 ]
  3. Chitturi S, George J: Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Semin Liver Dis. 2002;22(2):169-83. [PubMed:12016548 ]
  4. Cho H, Wolf KJ, Wolf EJ: Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution. Clin Ophthalmol. 2009;3:199-210. Epub 2009 Jun 2. [PubMed:19668566 ]
General function:
Involved in peroxidase activity
Specific function:
May play an important role in regulating or promoting cell proliferation in some normal and neoplastically transformed cells.
Gene Name:
PTGS1
Uniprot ID:
P23219
Molecular weight:
68685.82
References
  1. Waterbury LD, Silliman D, Jolas T: Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Curr Med Res Opin. 2006 Jun;22(6):1133-40. [PubMed:16846546 ]
  2. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]